Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2010

Open Access 01-11-2010

From the Editors’ Desk: What You Don’t Know Could Hurt You

Author: Mitchell D. Feldman, MD, MPhil

Published in: Journal of General Internal Medicine | Issue 11/2010

Login to get access

Excerpt

An e-mail that would have usually been categorized as “junk” somehow managed to elude the university spam filter and made its way into my in-box; the subject line read: “What Doctors Need to Know About Facebook.” The e-mail was inviting me to participate in a webinar that promised the participants that, among other wonders, they would learn to use Facebook as a “valuable tool for sharing information with colleagues.” Really? As a late and somewhat reluctant adopter of Facebook, I have been unconvinced of its value for me personally or professionally, and have mainly ignored the many “friend” requests that somehow began showing up in my e-mail after I finally signed up a few months ago; some came from patients and their families, some from people whose names I barely recognized (none, alas, from long lost flames). …
Metadata
Title
From the Editors’ Desk: What You Don’t Know Could Hurt You
Author
Mitchell D. Feldman, MD, MPhil
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 11/2010
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1505-8

Other articles of this Issue 11/2010

Journal of General Internal Medicine 11/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine